Singulair

Graphic image of a pill with the words safety on it

Pharma

NY attorney general wants FDA to tweak Singulair's safety label

Organon’s asthma med Singulair is back in the spotlight for the wrong reasons after New York's attorney general raised fresh safety concerns.

Fraiser Kansteiner Feb 27, 2024 9:25am

rear-view mirror

In FiercePharma's rearview mirror, a decade of industry-watching

Aug 7, 2017 10:26am